Concepedia

Harry Finch

HF

Statistics

Publications

47

Citations

2.7K

H-Index

24

Active since

1952

Affiliations

University of Hertfordshire(Current)

University of East Anglia

University of Liverpool

Wellcome Trust

Institute of Cancer Research

Harry Finch is an author at University of Hertfordshire specializing in medicinal chemistry, chemistry, and drug discovery.

ORCID

Publications per year

1952–2023

47

Publications

47

NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis

Suzanne A. Eccles, Andy Massey, Florence I. Raynaud et al. · Cancer Research · 2008 · 478 citations · Full text

, , +8

4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

Paul A. Brough, Wynne Aherne, Xavier Barril et al. · Journal of Medicinal Chemistry · 2007 · 445 citations · Full text

, , +11

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance

Diana Zatreanu, Helen M.R. Robinson, Omar Alkhatib et al. · Nature Communications · 2021 · 350 citations · Full text

, , +17

Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening against Protein Targets

Nicolas Baurin, Fareed Aboul‐ela, Xavier Barril et al. · Journal of Chemical Information and Computer Sciences · 2004 · 130 citations

, , +17

Polymer-supported hypervalent iodine reagents in ‘clean’ organic synthesis with potential application in combinatorial chemistry

Steven V. Ley, Andrew W. Thomas, Harry Finch · Journal of the Chemical Society Perkin Transactions 1 · 1999 · 105 citations

, , +9

1–5 of 47